Research programme: fluorine-based therapeutics/radiolabelled diagnostics - SciFluor Life Sciences

Drug Profile

Research programme: fluorine-based therapeutics/radiolabelled diagnostics - SciFluor Life Sciences

Alternative Names: SF 0034

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator SciFluor Life Sciences
  • Developer National Institute of Neurological Disorders and Stroke; SciFluor Life Sciences
  • Class Fluorine compounds; Radiopharmaceutical diagnostics
  • Mechanism of Action GABA A receptor agonists; Integrin alphaVbeta3 antagonists; KCNQ potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Age-related macular degeneration
  • Research Amyotrophic lateral sclerosis; Tinnitus
  • No development reported Partial epilepsies

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Partial-epilepsies in USA (PO)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Partial-epilepsies(Diagnosis) in USA (PO)
  • 08 Jan 2015 SciFluor Life Sciences has patent protection for SF 0034 in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top